CANS (complaints of the arm neck and/or shoulder)
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Positive impingement tests and significant reduction of pain for the same tests after an injection of 8 ml 1% lidocaïne in the subacromial area, Duration of shouderpain between 1/2 and 2 years, Age between 35 and 70 years, Patients accept the consequences of participation at the study
Exclusion criteria
Exclusion criteria: Anatomical abnormalities as dysplasie art. glenohumeralis, total cufftear etc. confirmed with radiography and/or sonography (with exception of minor arthrosis, calcifications and partial cufftears), Being operated at the shoulder or cervical spine, Reumatic diseases as polymyalgia rheumatica, artritis rheumatica, lupus erythematosis en fibromyalgia, Severe arthritis of the glenohumeral joint, The shoulder has been treated by three or more injections with cortisone, Professional sportactivities with severe stress on the shoulder (hockey, golf, javelin throwing), Severe disease or suspected of a severe disease (as malignities), Complaints in both shoulders, Severe trauma of the shoulder last 6 months, Neurologic disease with negative consequences for the shoulder (as CVA, MS, Parkinson), Diabetis mellitis with the dependence of insuline, Luxation or fracture of the shoulder in the past, Cervico-radicular syndrome, Pathology of organs with negative consequences for the shoulder, Demented, Psychiatric diseases, Insufficient understanding of the Dutch language, Very bad general condition, Very bad condition of the skin because of a skindisease, Allergic for tape.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| - Perceived overall improvement compared to baseline on a 7 point Likertscale. - Severity of perceived disability by means of the 'Disabilities of the Arm, Shoulder and Hand Scale' (DASH). | — |
Secondary
| Measure | Time frame |
|---|---|
| - Pain (VAS) - Individual disability measure - Mobility of the shoulder - 'Constant-Murley' score (a combination of pain, activities in daily life, mobility and strength) - Quality of life (Rand 36) - Cost-effectiveness (Health related quality of life and economic consequences will be assessed, the latter by means of a cost-diary. Costs of allocated treatment, direct and non-direct health care costs, and direct non-health care costs will be determined.) | — |
Countries
Netherlands